Kidiamix G

Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine and Phenylalanine, the active ingredients in Kidiamix G, are an amino‑acid solution presented as an intravenous infusion for parenteral nutrition use. It supplies essential amino acids required for protein synthesis and metabolic processes in patients unable to receive enteral feeding.

GNH USA supplies Kidiamix G as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and clinics worldwide, with the product originating from the European Union market, and adhering to stringent quality standards.

Kidiamix G, an amino‑acid solution for parenteral nutrition, is used in clinical situations where protein and amino‑acid support is required.

Parenteral nutrition: Provides essential amino acids for patients who cannot receive enteral feeding. Critically ill patients: Supports protein metabolism and nitrogen balance during intensive care. Surgical or trauma patients: Supplies amino‑acid supplementation to aid recovery after major operations or injury.

Kidiamix G may be associated with a range of infusion‑related reactions.

Common Side Effects: - Hyperglycaemia: Elevated blood glucose levels during infusion. - Electrolyte imbalance: Shifts in potassium, sodium or calcium concentrations. - Infusion site phlebitis: Redness or pain at the catheter site. - Nausea or mild vomiting.

Serious or Rare Side Effects: - Anaphylactic reaction: Severe allergic response requiring immediate medical intervention. - Severe hyperosmolarity: High osmolar load leading to renal stress. - Hepatic dysfunction: Abnormal liver enzyme elevations in susceptible patients.

Kidiamix G requires careful clinical monitoring to minimise risks.

Assess renal function: Adjust use in patients with impaired kidney clearance. Monitor electrolytes: Regularly check serum potassium, sodium and calcium levels. Check for metabolic disorders: Avoid in individuals with inborn errors of amino‑acid metabolism. Observe for hypersensitivity: Discontinue immediately if signs of allergic reaction appear. Use aseptic technique: Ensure sterility during preparation and administration. Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Kidiamix G can interact with other agents that affect electrolyte or metabolic balance.

Major Interactions (Avoid): - High‑dose potassium supplements: May cause dangerous hyperkalaemia. - Nephrotoxic drugs (e.g., aminoglycosides): Increase renal burden. - Intensive insulin therapy: Unpredictable glucose shifts during infusion.

Moderate Interactions (Monitor Closely): - Loop diuretics: May exacerbate electrolyte disturbances. - Corticosteroids: Can increase protein catabolism, altering amino‑acid needs. - Other parenteral nutrition solutions: Risk of incompatibility or excess nutrient load.